watch FREE this week.
Agree. Been following FREE for a while. It looks like it may finally run. It has reversed course.
Mr. Blitz brings to Great Basin more than two decades of building and leading sales teams that consistently exceed revenue and profit goals, including 19 years at Meridian Bioscience where, as director of regional sales and North American sales development, he and his team launched the illumigene molecular system and were responsible for 75 percent of the system’s revenues in the first two years of launch. Since Meridian, Mr. Blitz served as West Region sales manager at Nanosphere, reporting to the CEO and managing half the U.S. sales team. At Nanosphere, he and his team launched the Verigene Gram-Positive Blood Culture Test, where his team grew the business from $1.8 million in 2012 to more than $6.5 million in 2015, and secured over 150 new placements and multiple corporate contracts
today is the day smart shorts go long.
and they forgot to mention they hired the brain behind the competition, have 2 new FDA approvals.
Great Basin Scientific, Inc. (NASDAQ: GBSN) Is a molecular diagnostic testing company, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic systems that are designed to test hospital-acquired infections.
GBSN is up over 14% this morning after it announced its earnings analysis for Q4 of 2015 yesterday.
Obviously, GBSN has some more work do to get back to where it was just 6 months ago, however, their earnings analysis showed steady improvements.